TELA Bio (TELA) Enterprise Value (2019 - 2026)

TELA Bio has reported Enterprise Value for 8 years, with the latest figure at $12.6 million in Q2 2026.

• On a quarterly basis, Enterprise Value fell 69.78% year-over-year to $12.6 million in Q2 2026; TTM through Jun 2026 was $12.6 million, a 69.78% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 94.89% from the prior year.
• Enterprise Value was $12.6 million for Q2 2026 at TELA Bio, up from -$4.0 million in the prior quarter.
• The five-year high for Enterprise Value was $182.7 million in Q2 2023, with the low at -$4.0 million in Q1 2026.
• Average Enterprise Value over 5 years is $81.5 million, with a median of $81.9 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 145.78% in 2023, then sank 174.52% in 2026.
• Over 5 years, Enterprise Value stood at $178.4 million in 2022, then slumped by 35.29% to $115.4 million in 2023, then plunged by 70.99% to $33.5 million in 2024, then sank by 94.89% to $1.7 million in 2025, then jumped by 638.93% to $12.6 million in 2026.
• The last three Enterprise Value figures came in at $12.6 million (Q2 2026), -$4.0 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.